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Giulio
Superti-Furga
Editor of FEBS Letters since 1997Born in Italy and educated in Switzerland and Austria, Giulio
also worked for many years in Germany, ﬁrst at the EMBL
and then at Cellzome, a drug discovery company he co-
founded. ‘‘If there is an easier way to do something, an Italian
is likely to ﬁnd it; we don’t obey rules as eagerly as some other
cultures,’’ Giulio remarked during his recent interview with
FEBS Letters. Giulio has recently undertaken a new challenge
as the Director of the Center for Molecular Medicine at the
Austrian Academy of Sciences in Vienna, Austria. He edits pa-
pers for FEBS Letters in the systems biology, proteomics and
signal transduction areas.
What is your vision for the Center for Molecular Medicine?
I would like the Center to be interdisciplinary, combining in-
sight from both basic and medical research to produce useful
tools for clinicians. It should also have a relatively ﬂat hierar-
chy and a good mixture of natural and medical scientists. It
should be international and combine the best features of my
past work places: creativity and discipline, as well as keeping
in mind our medical goals.
What are you doing in your lab right now?
We are working on an interdisciplinary approach, using func-
tional proteomics and genomics to examine human protein
interaction pathways, particularly involving leukaemia and in-
nate immunity. We use chemical tools to probe the (patho)-
biological world. For example, by examining the interactions
of drugs with the networks, we ﬁnd agents that target particu-
larly sensitive control points, which may become targets for
therapeutic intervention or may help in diagnosis, prognosis
or therapy selection.
You once said ‘‘to manage is not to rule’’. What did you mean?
From my experience at Cellzome, I learned that there are many
simple management rules that business people know and re-
spect but academics tend to ignore. So much more could be
achieved in academic laboratories if they were managed in a
more dedicated fashion.
Are you speaking from personal experience?
Yes, absolutely. I made my share of mistakes when I started
my own group. When principal investigators start, they are un-
der so much pressure to succeed, it is tempting for them to act
like slave drivers. I have learned that for a good manager, there0014-5793/$30.00  2005 Published by Elsevier B.V. on behalf of the Feder
doi:10.1016/j.febslet.2005.03.005is no project or person that you can neglect. Another of my les-
sons is that, more often than not, women and men reach diﬀer-
ent solutions to the same problem. I tend to appreciate it when
discussions are carried out in a mixed-gender setting this en-
sures that there are a variety of opinions.
How do you view science?
Something like ‘‘truth-seeking’’ as a social event. I tend to
think better if I am together with other people, maybe this is
intellectual laziness (laughing), but I also think that this stems
from my Italian heritage; Italians are not loners.
What do you enjoy the most in your job?
I enjoy result interpretation, sitting around and brain-storming
the meaning of scientiﬁc observations with colleagues. I always
ﬁnd enchanting, exciting and amazing when one obtains an an-
swer that is more beautiful than the question itself. It is usually
our blinders that don’t permit us to see the purpose of biolog-
ical features.
Could you give an example?
One of the most exciting events in my scientiﬁc life was watch-
ing over John Williams shoulder as the electron density of the
protein Src coalesced into a structure on his computer screen
[1]. It gave me goose bumps to actually see the structural fea-
tures that we had predicted to exist and to discover additional
features that we had not. It was a beautiful and humbling re-
sult that explained so many of our previous experimental
observations.
Do you have a favourite paper?
I ﬁnd one paper by Patrick Brown’s group inspiring [2]. They
discovered something that should have been obvious but
wasn’t, namely that serum stimulation turns on a wound-heal-
ing response in human ﬁbroblasts. This is a beautiful example
of how a global perspective sheds completely new light on a
biological problem. For similar reasons, I am fond of our
2002 Nature publication [3], which has become a citation clas-
sic. It was an eureka moment to us when we realized that not
only is the proteome structured, but we had obtained bird’s eye
view of the organization of biological matter, a perspective
that nobody in the world had ever before achieved. This paper
is about creating order, not just more information, and I think
this is why people are still fascinated by it.
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